A Lower-Risk Way To Play This “High-Octane” Healthcare Trend
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…
“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than…
Sustainable investing has gone from niche to mainstream – and a number of the sustainable companies highlighted in today’s article put an emphasis on sustainability…
Whether markets continue to shrug off uncertainty, or become pervaded by it, the three dividend stocks highlighted in today’s article could prove to be good…
At the recent Sohn San Francisco Investment Conference, a number of up-and-coming hedge fund stars revealed their best stock ideas right now. For some of…
“Apple and Amazon shares have been great performers for years, while good, old AT&T hasn’t done much of anything,” notes the author of today’s article.…
It’s probably not a surprise to learn that the stocks that were the most adored by analysts at the start of 2018 beat the overall…
When it comes to achieving financial independence, there are factors you have little control over (such as the returns the market will provide). However, having…
With information from second-quarter hedge fund disclosures now publicly available, today’s article looks at which stocks the top-performing (but not necessarily well-known) hedge funds have…
Consider them “the second round of FANG stocks”: Baidu, Twitter, Tesla and Ali Baba. In today’s article, the author highlights what the price cycles of…